EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 18 / No 4 (Avril 2002) Med Sci (Paris), 18 4 (2002) 429-437 References
Free Access
Issue
Med Sci (Paris)
Volume 18, Number 4, Avril 2002
Page(s) 429 - 437
Section M/S Revues : Articles de Synthèse
DOI https://doi.org/10.1051/medsci/2002184429
Published online 15 April 2002
  1. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 1982; 42 : 4875–917. [Google Scholar]
  2. Okey AB. Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 1990; 45 : 241–98. [Google Scholar]
  3. Waxman DJ, Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 1992; 281 : 577–92. [Google Scholar]
  4. Frueh FW, Zanger UM, Meyer UA. Extent and character of phenobarbital-mediated changes in gene expression in the liver. Mol Pharmacol 1997; 51 : 363–9. [Google Scholar]
  5. Whysner J, Ross PM, Williams GM. Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 1996; 71 : 153–91. [Google Scholar]
  6. Kemper B. Regulation of cytochrome P450 gene transcription by phenobarbital. Prog Nucleic Acids Res Mol Biol 1998; 61 : 23–64. [Google Scholar]
  7. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1988; 40 : 243–88. [Google Scholar]
  8. Pitot HC, Dragan YP, Teeguarden J, Hsia S, Campbell H.Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol 1996; 24 : 119–28. [Google Scholar]
  9. Lee GH. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis. Toxicol Pathol 2000; 28 : 215–25. [Google Scholar]
  10. He JS, Fulco AJ. Abarbiturate-regulated protein binding to a common sequence in the cytochrome P450 genes of rodents and bacteria. J Biol Chem 1991; 266 : 7864–9. [Google Scholar]
  11. Honkakoski P, Negishi M. Regulatory DNA elements of phenobarbitalresponsive cytochrome P450 CYP2B genes. J Biochem Mol Toxicol 1998; 12 : 3–9. [Google Scholar]
  12. Trottier E, Belzil A, Stoltz C, Anderson A. Localization of a phenobarbital-responsive element (PBRE) in the 5’-flanking region of the rat CYP2B2 gene. Gene 1995; 158 : 263–8. [Google Scholar]
  13. Honkakoski P, Moore R, Gynther J, Negishi M. Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes. J Biol Chem 1996; 271 : 9746–53. [Google Scholar]
  14. Moore JT, Kliewer SA. Use of the nuclear receptor PXR to predict drug interactions. Toxicology 2000; 153 : 1–10. [Google Scholar]
  15. Dogra SC, Whitelaw ML, May BK. Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clin Exp Pharmacol Physiol 1998; 25: 1–9. [Google Scholar]
  16. Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 1999; 369 : 11–23. [Google Scholar]
  17. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 2000; 347 : 321–37. [Google Scholar]
  18. Zelko I, Negishi M. Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes. Biochem Biophys Res Commun 2000; 277 : 1–6. [Google Scholar]
  19. Corcos L, Weiss MC. Phenobarbital, dexamethasone and benzanthracene induce several cytochrome P450 mRNAs in rat hepatoma cells. FEBS Lett 1988; 233 : 37–40. [Google Scholar]
  20. Hansen AJ, May BK, Eferlink LA. Sequence of a chicken phenobarbital-inducible cytochrome P450 cDNA: regulation of two mRNAs transcribed from different genes. DNA 1989; 8 : 179–91. [Google Scholar]
  21. Shaw PM, Adesnik M, Weiss MC, Corcos L. The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU486. Mol Pharmacol 1993; 44 : 775–83. [Google Scholar]
  22. Hardwick J P, Gonzalez FJ, Kasper CB. Transcriptional regulation of rat liver epoxide hydratase, NADPH-cytochrome P-450 oxidoreductase, and cytochrome P-450b genes by phenobarbital. J Biol Chem 1983; 258 : 8081–5. [Google Scholar]
  23. Hahn CN, Hansen AJ, May BK. Transcriptional regulation of the chicken CYP2H1 gene. J Biol Chem 1991; 266 : 17031–9. [Google Scholar]
  24. Ramsden R, Sommer KM, Omiecinski CJ. Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J Biol Chem 1993; 268 : 21722–6. [Google Scholar]
  25. Lee SH, Wang X, DeJong J. Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1. Nucleic Acids Res 2000; 15 : 2091–8. [Google Scholar]
  26. Handschin C, Podvinec M, Meyer UA. CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 2000; 97 : 10769–74. [Google Scholar]
  27. Dogra SC, Benjamin P, Davidson P, May BK. Analysis of a phenobarbital-responsive enhancer sequence located in the 5’ flanking region of the chicken CYP2H1 gene: identification and characterization of functional protein-binding sites. Mol Pharmacol 1999; 55 : 14–22. [Google Scholar]
  28. Park Y, Li H, Kemper B. Phenobarbital induction mediated by a distal CYP2B2 sequence in rat transiently transfected in situ. J Biol Chem 1996; 271 : 23725–8. [Google Scholar]
  29. Honkakoski P, Moore R, Washburn K, NegishiM. Activation by diverse xenochemicals of the 51- bp phenobarbitalresponsive enhancer module of the Cyp2b10 gene. Mol Pharmacol 1998; 53 : 597–601. [Google Scholar]
  30. Honkakoski P, Negishi M. Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J Biol Chem 1997; 272 : 14943–9. [Google Scholar]
  31. Paquet Y, Trottier E, Beaudet MJ, Anderson A. Mutational analysis of the CYP2B2 phenobarbital response unit and inhibitory effect of constitutive androstane receptor on phenobarbital responsiveness. J Biol Chem 2000; 275 : 38427–36. [Google Scholar]
  32. Honkakoski P, Zelko I, Sueoshi T, Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbitalresponsive enhancer module of the CYP2B gene. Mol Cell Biol 1998; 18 : 5652–8. [Google Scholar]
  33. Quack M, Carlberg C. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J Mol Biol 2000; 296 : 743–56. [Google Scholar]
  34. Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 1999; 19: 6318–22. [Google Scholar]
  35. Sueyoshi T, Kawamoto T, ZelkoI I, Honkakoski P, Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B gene. J Biol Chem 1999; 274 : 6043–6. [Google Scholar]
  36. Kassam A, Winrow CJ, Fernandez-Rachubinski F, Capone JP, Rachubinski RA. The peroxisome proliferator response element of the gene encoding the peroxisomal betaoxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptorbeta/9-cisretinoic acid receptormediated transactivation. J Biol Chem 2000; 275 : 4345–50. [Google Scholar]
  37. Zhang B, Marcus SL, Sajjadi FG, et al. Identification of a peroxisome proliferatorresponsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci USA 1992 : 7541–7545. [Google Scholar]
  38. Yamada H, Yamaguchi T, Oguri K. Suppression of the expression of the CYP2B1/2 gene by retinoic acids. Biochem Biophys Res Commun 2000; 277 : 66–71. [Google Scholar]
  39. Wan YJ, Yu-Jui Y, Dahsing A, et al. Hepatocytespecific mutation establishes retinoid X receptor a as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000; 20 : 4436–44. [Google Scholar]
  40. Forman BM, Tzameli I, Choi HS, et al. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 1998; 395 : 612–5. [Google Scholar]
  41. Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000; 407 : 920–3. [Google Scholar]
  42. Moore LB, Park DJ, Jones SA, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000; 275 : 15122–7. [Google Scholar]
  43. Schuetz EG, Schmid W, Schutz G, et al. The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver. Drug Metab Dispos 2000; 28 : 268–78. [Google Scholar]
  44. Xie W, Barwick JL, Simon CM, et al. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 2000; 14 : 3014–23. [Google Scholar]
  45. Nirodi CS, Sultana S, Ram N, Prabhu L, Padmanaban G. Involvement of synthesis and phosphorylation of nuclear protein factors that bind to the positive cis-acting element in the transcriptional activation of the CYP2B1/B2 gene by phenobarbitone in vivo. Arch Biochem Biophys 1996; 331 : 79–86. [Google Scholar]
  46. Kawamura A, Yoshida Y, Kimura N, Oda H, Kakinuma A. Phosphorylation/ dephosphorylation steps are crucial for the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital. Biochem Biophys Res Commun 1999; 264 : 530–6. [Google Scholar]
  47. Dogra SC, May BK. Phenobarbital-induced activation of CYP2H1 and 5-aminolevulinate synthase genes in chick embryo hepatocytes is blocked by an inhibitor of protein phosphorylation. Arch Biochem Biophys 1996; 327 : 271–8. [Google Scholar]
  48. Sidhu JS, Omiecinski CJ. cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures. J Biol Chem 1995; 270 : 12762–73. [Google Scholar]
  49. Marc N, Galisteo M, Lagadic-Gossmann D, et al. Regulation of phenobarbital induction of the cytochrome P450 2b9/10 genes in primary mouse hepatocyte culture. Involvement of calciumand cAMP-dependent pathways. Eur J Biochem 2000; 267 : 963–70. [Google Scholar]
  50. Sidhu JS, Omiecinski CJ. An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther 1997; 282 : 1122–9. [Google Scholar]
  51. Geng J, Strobel HW. Expression, induction and regulation of the cytochrome P450 monooxygenase system in the rat glioma C6 cell line. Brain Res 1998; 784 : 276–83. [Google Scholar]
  52. Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P, Vilarem MJ. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 2000; 58 : 1441–1450. [Google Scholar]
  53. Damon M, Fautrel A, Guillouzo A, Corcos L. Genetic analysis of the phenobarbital regulation of the cytochrome P-450 2b-9 and aldehyde dehydrogenase type 2 mRNAs in mouse liver. Biochem J 1996; 317 : 481–6. [Google Scholar]
  54. Dunn TJ, Koleske AJ, Lindahl R, Pitot HC. Phenobarbitalinducible aldehyde dehydrogenase in the rat. cDNA sequence and regulation of the mRNA by phenobarbital in responsive rats. J Biol Chem 1989; 264 : 13057–65. [Google Scholar]
  55. MarcN, Fautrel A, Damon M, Guillouzo A, Corcos L. Phenobarbital induction of aldehyde dehydrogenase type 2 mRNA in mouse liver: a candidate region on chromosome 7 for a putative regulatory gene. Biochem Genet 2000; 38 : 288–98. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.